Intra Cellular Therapies reported $-69141060 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -43709000 23.06M
Aptinyx Inc APTX:US $ -19866000 5.58M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
Biocryst Pharmaceuticals BCRX:US $ -29582000 21.8M
Biogen BIIB:US $ 1030.1M 12.3M
Bristol Myers Squibb BMY:US $ 2967M 411M
Cytokinetics CYTK:US $ -54797000 14.19M
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Gilead Sciences GILD:US $ 2262M 639M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Halozyme Therapeutics HALO:US $ 93.05M 42.31M
Intra Cellular Therapies ITCI:US $ -69141060 15.92M
JAZZ PHA JAZZ:US -69590000 231.71M
Johnson & Johnson JNJ:US $ 6901M 94M
Marinus Pharmaceuticals MRNS:US -23485000 3.68M
Minerva Neurosciences NERV:US $ -8963290 1.46M
Nektar Therapeutics NKTR:US $ -110205000 813K
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Novartis NVS:US 3.4B 415M
Prothena PRTA:US 27.95M 60.06M
Redhill Biopharma RDHL:US -24886000 6.73M
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
United Therapeutics UTHR:US $ 222.2M 263.9M
Vanda Pharmaceuticals VNDA:US $ 12.37M 2.03M
Zogenix ZGNX:US $ -55431000 3.63M